MedTrace Logo

Use of Minocycline in Intracerebral Hemorrhage

NCT03040128 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-02-02

No results posted yet for this study

Summary

To date, no neuroprotective drugs have demonstrated clinical efficacy in intracerebral hemorrhage (ICH). This study will use intravenous (IV) minocycline in ICH to evaluate for (1) safety/ tolerability and (2) evaluate for clinical efficacy

Conditions

  • Intracerebral Hemorrhage

Interventions

DRUG

Minocycline

high-dose, intravenous minocycline

OTHER

normal saline infusion

Sponsors & Collaborators

  • University of Southern California

    collaborator OTHER

  • University of Tennessee

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-27
Primary Completion
2016-11-30
Completion
2016-11-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03040128 on ClinicalTrials.gov